Knowledge Center

Article / Sep 23, 2014

Quality Metrics - A Case for an FDA Dean's List

Authors:
  • Guy Villax
Source:
Pharmaceutical Technology, September 2014

The author (Guy Villax) presents arguments for an FDA Dean's List as a means to drive the right behaviors in the industry.

FDA is moving in the right direction when it looks to rank quality across pharmaceutical manufacturing sites. However quality is a matter of culture rather than metrics or compliance.

  • Read the extended version with links to references, examples and case studies here
  • Read the article in Pharmaceutical Technology  here

 

Also in the Knowledge Center

Related Content

Drug delivery platforms

Hovione has unique capabilities and expertise in solubility enhancement, lung delivery, modified release and taste-masking applications.

Page
Read more

Drug Product Development

Leveraging our expertise particle engineering, Hovione can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more

Development by Design

Development by Design is Hovione’s proven spray-dried dispersion scale-up and tech-transfer methodology.

Page
Read more